Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

CTP-543 is generally safe for treating alopecia areata.